ArticleThe Journal of general virology2026
Conserved histidine residues and the control of tick-borne encephalitis virus maturation.
Article in The Journal of general virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The maturation and infectivity of orthoflaviviruses is driven by interactions and structural changes of the two envelope proteins, prM and E, which are controlled by protonation and deprotonation events during the viral life cycle when the virus encounters acidic and neutral pH environments inside and outside the cell. Histidine residues act as sensors for these pH-induced conformational transitions, which differ between mosquito-borne and tick-borne orthoflaviviruses in some aspects. We identified six histidine residues that are conserved among the envelope proteins of mammalian tick-borne orthoflaviviruses, but not among those of mosquito-borne orthoflaviviruses. These residues might account for some of the structural differences observed between these two orthoflavivirus groups. We therefore conducted a mutational analysis by replacing each of the conserved histidine residues with alanine and determined the effect of these mutations on the maturation and infectivity of tick-borne encephalitis virus (TBEV). One of the histidine residues (H208, located in an insert unique to mammalian tick-borne orthoflaviviruses at the prM-binding site in E) was shown to be an important determinant of efficient prM cleavage. In line with recent findings regarding the infectivity of immature tick-borne orthoflaviviruses, this mutant was only slightly less infectious than the mature wild-type virus. The presence of histidine residue 208 appears to be linked to the particular requirements of the complex ecological life cycle of TBEV and likely reflects an evolutionary adaptation to the specific interactions of the virus with mammalian hosts and/or tick vectors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.